Cytokinetics
Developer of muscle-directed medicines led by MYQORZO for hypertrophic cardiomyopathy.
$72.50
After-hours close+0.39 (+0.54%)
At close$72.11(−7.43%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$1.45 | — | — |
| Aug 2026 | −$1.63 | −$1.50 | +8.0% |
| May 2026 | −$1.67 | −$1.67 | 0.0% |
| Feb 2026 | −$1.48 | −$1.50 | −1.4% |
| Nov 2025 | −$1.59 | −$1.54 | +3.1% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Oct 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Jul 2018 | |||
| Apr 2018 | |||
| Feb 2018 | |||
| Oct 2017 | |||
| Aug 2017 | |||
| Apr 2017 | |||
| Feb 2017 | |||
| Oct 2016 | |||
| Jul 2016 | |||
| Apr 2016 | |||
| Feb 2016 | |||
| Oct 2015 | |||
| Jul 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | −$1.45 | — | — | $39.8M | — | — |
| Aug 6, 2026 | −$1.63 | −$1.50 | +8.0% | $17.6M | $28.6M | +62.7% |
| May 5, 2026 | −$1.67 | −$1.67 | 0.0% | $8.5M | $19.4M | +127.2% |
| Feb 24, 2026 | −$1.48 | −$1.50 | −1.4% | $6.9M | $17.8M | +156.3% |
| Nov 5, 2025 | −$1.59 | −$1.54 | +3.1% | $8.0M | $1.9M | −75.9% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 7, 2025 | ||||||
| May 6, 2025 | ||||||
| Feb 27, 2025 | ||||||
| Nov 6, 2024 | ||||||
| Aug 8, 2024 | ||||||
| May 8, 2024 | ||||||
| Feb 27, 2024 | ||||||
| Nov 2, 2023 | ||||||
| Aug 3, 2023 | ||||||
| May 4, 2023 | ||||||
| Mar 1, 2023 | ||||||
| Nov 3, 2022 | ||||||
| Aug 4, 2022 | ||||||
| May 4, 2022 | ||||||
| Feb 24, 2022 | ||||||
| Nov 3, 2021 | ||||||
| Aug 5, 2021 | ||||||
| May 6, 2021 | ||||||
| Feb 25, 2021 | ||||||
| Nov 4, 2020 | ||||||
| Aug 6, 2020 | ||||||
| May 6, 2020 | ||||||
| Mar 3, 2020 | ||||||
| Oct 31, 2019 | ||||||
| Aug 8, 2019 | ||||||
| May 9, 2019 | ||||||
| Feb 21, 2019 | ||||||
| Nov 1, 2018 | ||||||
| Jul 26, 2018 | ||||||
| Apr 26, 2018 | ||||||
| Feb 15, 2018 | ||||||
| Oct 26, 2017 | ||||||
| Aug 2, 2017 | ||||||
| Apr 27, 2017 | ||||||
| Feb 16, 2017 | ||||||
| Oct 27, 2016 | ||||||
| Jul 28, 2016 | ||||||
| Apr 28, 2016 | ||||||
| Feb 16, 2016 | ||||||
| Oct 29, 2015 | ||||||
| Jul 29, 2015 | ||||||